VanEck Biotech ETF (NASDAQ:BBH) Sees Unusually-High Trading Volume – Still a Buy?

VanEck Biotech ETF (NASDAQ:BBH) shares saw an uptick in trading volume on Thursday. 4,806 shares traded hands during mid-day trading, a decline of 34% from the previous session’s volume of 7,289 shares. The stock last traded at $251.1030 and had previously closed at $250.46.

VanEck Biotech ETF Trading Down 0.8%

The company has a 50 day simple moving average of $239.09 and a 200 day simple moving average of $210.75.

Institutional Trading of VanEck Biotech ETF

Large investors have recently made changes to their positions in the company. Coastline Trust Co acquired a new stake in shares of VanEck Biotech ETF in the third quarter valued at about $46,000. CoreCap Advisors LLC acquired a new position in VanEck Biotech ETF during the third quarter worth about $46,000. Manchester Capital Management LLC acquired a new position in VanEck Biotech ETF during the third quarter worth about $74,000. SBI Securities Co. Ltd. purchased a new stake in VanEck Biotech ETF in the 3rd quarter valued at $74,000. Finally, First PREMIER Bank acquired a new stake in VanEck Biotech ETF during the 2nd quarter worth $91,000. 32.05% of the stock is currently owned by hedge funds and other institutional investors.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.